Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Hace 1 día · I found some info in related questions: SQLAlchemy + alembic: create schema migration and How to specific table schema for alembic_version when using flask-migrate and Create an alembic migration to create schema for version_table_schema, but I'm strugginling to put them together in one (or two) neat migration + code changes.

  2. Hace 5 días · Answer: Alembic is a file format for storing and exchanging 3D assets. OpenUSD also fulfills this role of interchange of 3D data with additional core schemas that represent a greater variety of CG primitives than Alembic.

  3. Hace 5 horas · Alembic Pharmaceuticals Ltd shares gained nearly 3% on Thursday after the company announced receiving final approval from the United States Food and Drug Administration (USFDA) for Sacubitril and Valsartan tablets. In a stock exchange filing, Alembic Pharmaceuticals Ltd said that the company has received the final approval from the US drug ...

  4. Hace 5 horas · Vadodara: Alembic Pharmaceuticals Limited has announced that the Company has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Sacubitril and Valsartan Tablets, 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg. The approved ANDA is therapeutically equivalent to the reference ...

  5. Hace 3 horas · Alembic Pharmaceuticals: Sacubitril and Valsartan tablets are indicated to reduce the risk of cardiovascular death and hospitalisation for heart failure in adult patients with chronic heart failure.

  6. Hace 16 horas · Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Sacubitril and Valsartan Tablets, 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD ...

  7. Hace 16 horas · BILKULONLINE. Mumbai, May 30: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Sacubitril and Valsartan Tablets, 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg.The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD ...